Use access key #2 to skip to page content.
$4.99 0.15 (3.10%)
10/10/2008 4:00 PM

ZymoGenetics, Inc. (ZGEN)

CAPS Rating:
***

The Company is focused on the discovery, development, manufacture and commercialization of therapeutic proteins for the treatment of human diseases.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating ZGEN

Add Stock to Watchlist

What the Community Thinks

Total Members

105 Outperforms
23 Underperforms
 

All-Stars

35 Outperforms
10 Underperforms
 

Wall Street

8 Outperforms
1 Underperforms
 

Members bullish on ZGEN are also bullish on:

Members bearish on ZGEN are also bearish on:

Ticker Tags

Biotechnology (295), Small Cap (1922), Rule Breakers Universe (161)
Suggest a tag

ZymoGenetics, Inc. At A Glance

Current Price: $4.99
Last Trade Time: 10/10/2008 4:00 PM
Open: $4.57
Previous Close: $4.84
Daily Range: $4.20 - $5.14
52-Week Range: $4.77 - $15.23
Volume: 476,294
Market Cap: $332.62M
P/E Ratio: 0.00
Compare Our Special Broker Offers!

Stock Trends

ZGEN VS S&P 500 (SPY)

ZGEN 12 month chart vs. S&P

News & Discussion Boards

Other News Headlines for ZGEN

More Headlines...

Top Bull Pitch

Recs

1

ZymoGenetics, Inc. (ZGEN)

Avatar morningstarboy (80.09) Submitted: 2/21/08 1:02 PM

As of close of business on 2/20/08, this was a 5-star Morningstar stock trading at less than half of its Morningstar fair value.

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

1

ZymoGenetics, Inc. (ZGEN)

Avatar glennwhiteside (< 20) Submitted: 5/28/08 2:27 AM

Sales estimates for recothrom are being revised down, IL-21 is a nonstarter and atacicept is a long ways off. This stock might have one last surge left in it but after that it's going to be history, probably within two years.

Replies: 0 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 19 :   1 2 3 4 Next »

Recs

0

 (ZGEN)

Avatar BruceInCola (34.39) Submitted: 5/07/08 10:57 AM : Outperform Start Price: $9.43 ZGEN Score: -10.37

$18

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ZGEN)

Avatar sjflorczyk (< 20) Submitted: 4/20/08 10:50 PM : Outperform Start Price: $9.52 ZGEN Score: -11.57

Industry ripe for growth and currently (4/20/08) at a low.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ZGEN)

Avatar kopacetic24 (58.03) Submitted: 3/26/08 1:38 AM : Outperform Start Price: $10.00 ZGEN Score: -15.92

This company is trading near it's yearly low as well as a major executive (CEO or director) recently made a big purchase of stocks.

Report this Post Replies: 0 | Reply | Permalink

Recs

1

 (ZGEN)

Avatar morningstarboy (80.09) Submitted: 2/21/08 1:02 PM : Outperform Start Price: $9.17 ZGEN Score: -10.99

As of close of business on 2/20/08, this was a 5-star Morningstar stock trading at less than half of its Morningstar fair value.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ZGEN)

Avatar nealandali (< 20) Submitted: 2/17/08 11:40 AM : Outperform Start Price: $9.23 ZGEN Score: -10.68

Will be @16-17,in 6 mos.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 19 :   1 2 3 4 Next »

Wall Street

Results 1 - 9 of 9  

picks per page. CHANGE Expand All Pitches

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackEveillard 89.21 03/31/08 Outperform NS $9.80-49.08%-32.94%-16.14 Toggle the visibility of 60-Second Pitch and replies
TrackZacks 80.22 02/15/08 Outperform 3M $9.10-45.16%-34.51%-10.65 Toggle the visibility of 60-Second Pitch and replies
TrackBreanMurray 94.74 02/14/08 Outperform NS $9.22-45.88%-35.38%-10.50
TrackUBS 83.70 01/29/08 Outperform NS $10.78-53.71%-34.97%-18.74
TrackSoros 84.59 09/30/07 Outperform NS $13.05-61.76%-42.00%-19.76 Toggle the visibility of 60-Second Pitch and replies
TrackStanfordRes 73.73 08/02/07 Outperform NS $12.00-58.42%-39.70%-18.72
TrackBearStearns 89.07 03/09/07 Outperform NS $15.86-68.54%-37.37%-31.17
TrackAGEdwards 89.97 01/04/07 Outperform NS $15.32-67.43%-37.34%-30.09
TrackJimCramer 81.55 11/09/06 Underperform 3W $15.71-68.24%-36.01%+32.23
TrackInfiniumSec None 08/17/06 Outperform NS $19.00-73.74%-31.20%-42.54

Results 1 - 9 of 9  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners